Psychiatric aspects of Wilson disease: A review

General Hospital Psychiatry

Volumn 36, Issue 1, 2014, Pages 53-62

  Zimbrean, Paula C ^a,b   Schilsky, Michael L ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Ceruloplasmin; Copper; Psychiatry; Schizophrenia; Wilson's disease

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIPARKINSON AGENT; BIPERIDEN; CARBAMAZEPINE; CERULOPLASMIN; CHLORPROMAZINE; CLOMIPRAMINE; COPPER; FLUOXETINE; HALOPERIDOL; LITHIUM; LORAZEPAM; MIANSERIN; NEUROLEPTIC AGENT; PENICILLAMINE; PERPHENAZINE; PIPAMPERONE; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; WILSON DISEASE PROTEIN; ZINC; ZUCLOPENTHIXOL;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATP7B GENE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHELATION THERAPY; CHILD; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC ERROR; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; GENE MUTATION; GENERALIZED ANXIETY DISORDER; GENETIC SCREENING; HUMAN; LABORATORY TEST; LIVER DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MENTAL DISEASE; MIDDLE AGED; NEUROIMAGING; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY; PERSONALITY DISORDER; PRESCHOOL CHILD; PREVALENCE; PSYCHOSIS; PSYCHOTHERAPY; SCHIZOPHRENIA; SCHOOL CHILD; SUICIDE ATTEMPT; WILSON DISEASE; YOUNG ADULT;

CERULOPLASMIN; COPPER; PSYCHIATRY; SCHIZOPHRENIA; WILSON'S DISEASE;

DEPRESSIVE DISORDER, MAJOR; HEPATOLENTICULAR DEGENERATION; HUMANS; MENTAL DISORDERS; PERSONALITY DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84891277400     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.08.007     Document Type: Article

References (125)

1. Coffey A.J., Durkie M., Hague S., et al. A genetic study of Wilson's disease in the United Kingdom. Brain 2013, 136(5):1476-1487.
2. Roberts E.A., Schilsky M.L. A practice guideline on Wilson disease. Hepatology 2003, 37(6):1475-1492.
3. Denny-Brown D., Porter H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med 1951, 245(24):917-925.
4. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956, 21(4):487-495. Accessed 8/2/2013 1:53:47 PM.
5. Brewer G.J. Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother 2001, 2(9):1473-1477. 10.1517/14656566.2.9.1473.
6. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. The Lancet 1982, 319(8273):643-647.
7. Kinnier-Wilson S. Progressive lenticular degeneration -a familial nervous disease associated with cirrhosis of the liver. Brain. 1912, 34:295-298.
8. Rathbun J.K. Neuropsychological aspects of Wilson's disease. Int J Neurosci 1996, 85(3-4):221-229.
9. Prashanth L.K., Taly A.B., Sinha S., Arunodaya G.R., Swamy H.S. Wilson's disease: diagnostic errors and clinical implications. Journal of Neurology, Neurosurgery & Psychiatry. 2004, 75(6):907-909.
10. Akil M., Schwartz J.A., Dutchak D., Yuzbasiyan-Gurkan V., Brewer G.J. The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci 1991, 3(4):377-382.
11. Dening T.R., Berrios G.E. Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry Dec 1989, 46(12):1126-1134.
12. Carr A., McDonnell D.J. Wilson's disease in an adolescent displaying an adjustment reaction to a series of life stressors: a case study. Child Psychology & Psychiatry & Allied Disciplines Sep 1986, 27(5):697-700.
13. Chung Y.S., Ravi S.D., Borge G.F. Psychosis in Wilson's disease. Psychosomatics: Journal of Consultation Liaison Psychiatry Jan 1986, 27(1):65-66.
14. Bouix J., Courtine P., Alezrah C. Wilson's disease and psychiatry. Apropos of a case. Encephale 1987, 13(3):113-116.
15. Awada A. al Rajeh S, al Qorain A, al Ghassab G. [Wilson's disease in a Saudi Arabian female patient. Rapid changes in cerebral x-ray computed tomography]. Rev Neurol 1990, 146(4):306-307.
16. Buckley P., Carmody E., Hutchinson M. Wilson's disease and the neuroleptic malignant syndrome. Irish Journal of Psychological Medicine Sep 1990, 7(2):138-139.
17. Saint-Laurent M. Schizophrenia and Wilson's disease. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 1992, 37(5):358-360. Accessed 1/22/2012 6:04:25 PM. http://ovidsp.ovid.com/ovidweb.cgiT=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med3&AN=1353405.
18. Davis E.J., Borde M. Wilson's disease and catatonia. The British Journal of Psychiatry 1993, 162:256-259.
19. Gwirtsman H.E., Prager J., Henkin R. Case report of anorexia nervosa associated with Wilson's disease. Int J Eat Disord 1993, 13(2):241-244.
20. Garnier H., Diederich N., Pilloy W., Lenaerts M., Dooms G., Metz H. Late form with psychiatric presentation of Wilson's disease, with pseudo-compulsive stereotyped movements. Neuro-radiological correlations. Rev Neurol 1997, 153(2):124-128. Accessed 19971001; 4/17/2013 3:03:13 PM.
21. Shah N., Kumar D. Wilson's disease, psychosis, and ECT. Convuls Ther 1997, 13(4):278-279.
22. Walter G., Lyndon B. Depression in hepatolenticular degeneration (Wilson's disease). Aust N Z J Psychiatry 1997, 31(6):880-882.
23. Keller R., Torta R., Lagget M., Crasto S., Bergamasco B. Psychiatric symptoms as late onset of Wilson's disease: Neuroradiological findings, clinical features and treatment. Ital J Neurol Sci 1999, 20(1):49-54.
24. Muller J., Landgraf F., Trabert W. Schizophrenia-like symptoms in the westphal-strumpell variation of Wilson disease. Nervenarzt 1998, 69(3):264-268.
25. Muller J.L. Schizophrenia-like symptoms in the westphal-strumpell form of Wilson's disease. J Neuropsychiatry Clin Neurosci 1999, 11(3):412.
26. Stiller P., Kassubek J., Schonfeldt-Lecuona C., Connemann B.J. Wilson's disease in psychiatric patients. Psychiatry Clin Neurosci 2002, 56(6):649. 10.1046/j.1440-1819.2002.01071.x.
27. Rodrigues A.C., Dalgalarrondo P. Neuropsychiatric disturbances in Wilson's disease and use of electroconvulsive therapy: case report. Arq Neuropsiquiatr 2003, 61(3B):876-880.
28. Sagawa M., Takao M., Nogawa S., et al. Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura. No to Shinkei - Brain & Nerve 2003, 55(10):899-902.
29. Shah H., Vankar G.K. Wilson's disease: a case report. Indian J Psychiatry 2003, 45(4):253-254.
30. Smit J.P., De Graaf J., Tjabbes T., Kloek J. Depression as first symptom of Wilson's disease. A case study. Tijdschrift voor Psychiatrie 2004, 46(4):255-258.
31. Chan K.H., Cheung R.T., Au-Yeung K.M., Mak W., Cheng T.S., Ho S.L. Wilson's disease with depression and Parkinsonism. Journal of Clinical Neuroscience 2005, 12(3):303-305.
32. Krishnakumar P., Riyaz A. Wilson's disease presenting as depressive disorder. Indian Pediatr 2005, 42(11):1172-1173.
33. Chand P.K., Murthy P. Mania as a presenting symptom of Wilson's disease. Acta Neuropsychiatrica Feb 2006, 18(1):47-49.
34. Jukic I., Titlic M., Tonkic A., Dodig G., Rogosic V. Psychosis and Wilson's disease: a case report. Psychiatria Danubina 2006, 18(1-2):105-107.
35. Barbosa E.R., Silveira-Moriyama L., Machado A.C., Bacheschi L.A., Rosemberg S., Scaff M. Wilson's disease with myoclonus and white matter lesions. Parkinsonism Relat Disord 2007, 13(3):185-188.
36. Benhamla T., Tirouche Y.D., Abaoub-Germain A., Theodore F. The onset of psychiatric disorders and Wilson's disease. Encephale 2007, 33(6):924-932.
37. Kumawat B.L., Sharma C.M., Tripathi G., Ralot T., Dixit S. Wilson's disease presenting as isolated obsessive-compulsive disorder. Indian J Med Sci 2007, 61(11):607-610.
38. Lin J.J., Lin K.L., Wang H.S., Wong M.C. Psychological presentations without hepatic involvement in Wilson disease. Pediatr Neurol 2006, 35(4):284-286. 10.1016/j.pediatrneurol.2006.04.004.
39. Machado A.C., Deguti M.M., Caixeta L., Spitz M., Lucato L.T., Barbosa E.R. Mania as the first manifestation of Wilson's disease. Bipolar Disord 2008, 10(3):447-450. doi: http://dx.doi.org/10.1111/j.1399-5618.2007.00531.x; http://dx.doi.org/10.1111/j.1399-5618.2007.00531.x.
40. Aggarwal A., Bhatt M. Eye sign in an 18 year old man with psychosis. BMJ. 2009, 339:b3494. 10.1136/bmj.b3494.
41. Aravind V.K., Krishnaram V.D., Neethiarau V., Srinivasan K.G. Wilson's disease-a rare psychiatric presentation. J Indian Med Assoc 2009, 107(7):456-457.
42. Habek M., Gabeli T., Brinar V.V., Pavli G. Late-onset Wilson's disease presenting with general anxiety disorder. Acta Neuropsychiatrica Oct 2009, 21(5):267-268.
43. Chakor R.T., Santhosh N.S. Severe neuropsychiatric presentation of Wilson's disease. Indian J Psychiatry 2011, 53(2):170-171. 10.4103/0019-5545.82556; 10.4103/0019-5545.82556.
44. Alva-Moncayo E., Castro-Tarin M., Gonzalez-Serrano A. Wilson disease. A case report and review of the literature. Rev Med Inst Mex Seguro Soc. 2011, 49(3):331-334.
45. Silva F., Nobre S., Campos A.P., Vasconcelos M., Goncalves I. Behavioural and psychiatric disorders in paediatric Wilson's disease. BMJ Case Rep 2011, 2011:http://dx.doi.org/10.1136/bcr.05.2011.4249.
46. Nayak R.B., Shetageri V.N., Bhogale G.S., Patil N.M., Chate S.S., Chattopadhyay S. Catatonia: a rare presenting symptom of Wilson's disease. J Neuropsychiatry Clin Neurosci 2012, 24(3):E34-E35.
47. Oder W., Grimm G., Kollegger H., Ferenci P., Schneider B., Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol 1991, 238(5):281-287.
48. Dening T.R., Berrios G.E. Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989, 46(12):1126-1134.
49. Medalia A., Scheinberg I.H. Psychopathology in patients with Wilson's disease. Am J Psychiatry 1989, 146(5):662-664.
50. Dening T.R., Berrios G.E. Wilson's disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry 1990, 28(3):255-265.
51. Portala K., Westermark K., von Knorring L., Ekselius L. Psychopathology in treated Wilson's disease determined by means of CPRS expert and self-ratings. Acta Psychiatr Scand 2000, 101(2):104-109.
52. Portala K., Westermark K., Ekselius L., Broman J. Sleep in patients with treated Wilson's disease. A questionnaire study. Nordic Journal of Psychiatry. 2002, 56(4):291-297.
53. Seniow J., Mroziak B., Czlonkowska A., Jedryka-Goral A. Self-rated emotional functioning of patients with neurological or asymptomatic form of Wilson's disease. Clin Neuropsychol 2003, 17(3):367-373. Accessed 20040105; 4/17/2013 3:03:13 PM.
54. Shanmugiah A., Sinha S., Taly A.B., et al. Psychiatric manifestations in Wilson's disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci 2008, 20(1):81-85. doi: http://dx.doi.org/10.1176/appi.neuropsych.20.1.81; http://dx.doi.org/10.1176/appi.neuropsych.20.1.81.
55. Svetel M., Potrebic A., Pekmezovic T., et al. Neuropsychiatric aspects of treated Wilson's disease. Parkinsonism Relat Disord 2009, 15(10):772-775. doi: http://dx.doi.org/10.1016/j.parkreldis.2009.01.010; http://dx.doi.org/10.1016/j.parkreldis.2009.01.010.
56. Nevsimalova S., Buskova J., Bruha R., et al. Sleep disorders in Wilson's disease. Eur J Neurol 2011, 18(1):184-190. doi: http://dx.doi.org/10.1111/j.1468-1331.2010.03106.x; http://dx.doi.org/10.1111/j.1468-1331.2010.03106.x.
57. Carta M.G., Sorbello O., Moro M.F., et al. Bipolar disorders and Wilson's disease. BMC Psychiatry 2012, 12(1):52.
58. Gunther P., Hermann W. Mild cognitive impairment and depressive symptoms in patients with Wilson's disease under long-term therapy. Fortschr Neurol 2012, 80(3):149-153.
59. Huang C.C., Chu N.S. Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series. J Formos Med Assoc 1992, 91(5):502-507.
60. Bono W., Moutie O., Benomar A., et al. Wilson's disease. Clinical presentation, treatment and evolution in 21 cases. Revue de Medecine Interne 2002, 23(5):419-431.
61. Pan J.J., Chu C.J., Chang F.Y., Lee S.D. The clinical experience of Chinese patients with Wilson's disease. Hepatogastroenterology 2005, 52(61):166-169.
62. Soltanzadeh A., Soltanzadeh P., Nafissi S., Ghorbani A., Sikaroodi H., Lotfi J. Wilson's disease: a great masquerader. Eur Neurol 2007, 57(2):80-85. 10.1159/000098056.
63. Srinivas K., Sinha S., Taly A.B., et al. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!. J Neurol Sci. 2008, 266(1-2):104-108. 10.1016/j.jns.2007.09.009.
64. Mercier-Jacquier M., Bronowicki J.P., Raabe J.J., Jacquier A., Kaminsky P. Wilson's disease in an adult. Revue de Medecine Interne 2011, 32(6):341-346.
65. Dening T.R., Berrios G.E. Wilson's disease: a prospective study of psychopathology in 31 cases. The British Journal of Psychiatry 1989, 155:206-213.
66. Dening T.R., Berrios G.E. Wilson's disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry Aug 1990, 28(3):255-265.
67. Huang C.C., Chu N.S. Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series. J Formosan Med Assoc 1992, 91(5):502-507.
68. Baban N.K., Hubbs D.T., Roy T.M. Wilson's disease. South Med J 1997, 90(5):535-538.
69. McDonald L.V., Lake C.R. Psychosis in an adolescent patient with Wilson's disease: effects of chelation therapy. Psychosom Med 1995, 57(2):202-204.
70. Modai I., Karp L., Liberman U.A., Munitz H. Penicillamine therapy for schizophreniform psychosis in Wilson's disease. J Nerv Ment Dis 1985, 173(11):698-701.
71. Chroni E., Lekka N.P., Tsibri E., Economou A., Paschalis C. Acute, progressive akinetic rigid syndrome induced by neuroleptics in a case of Wilson's disease. J Neuropsychiatry Clin Neurosci 2001, 13(4):531-532.
72. Kulaksizoglu I.B., Polat A. Quetiapine for mania with Wilson's disease. Psychosomatics 2003, 44(5):438-439. 10.1176/appi.psy.44.5.438.
73. Chahine L.M., Chemali Z.N. The bane of a silent illness: when Wilson's disease takes its course. Int J Psychiatry Med 2006, 36(3):333-338.
74. Wichowicz H.M., Cubala W.J., Slawek J. Wilson's disease associated with delusional disorder. Psychiatry & Clinical Neurosciences 2006, 60(6):758-760.
75. Loganathan S., Nayak R., Sinha S., Taly A.B., Math S., Varghese M. Treating mania in Wilson's disease with lithium. J Neuropsychiatry Clin Neurosci 2008, 20(4):487-489. doi: http://dx.doi.org/10.1176/appi.neuropsych.20.4.487; http://dx.doi.org/10.1176/appi.neuropsych.20.4.487.
76. Spyridi S., Diakogiannis I., Michaelides M., Sokolaki S., Iacovides A., Kaprinis G. Delusional disorder and alcohol abuse in a patient with Wilson's disease. Gen Hosp Psychiatry 2008, 30(6):585-586. doi: http://dx.doi.org/10.1016/j.genhosppsych.2008.05.005; http://dx.doi.org/10.1016/j.genhosppsych.2008.05.005.
77. Varghese S.T., Narayanan D., Dinesh D. Mania in a patient with Wilson's disease awaiting liver transplant. J Neuropsychiatry Clin Neurosci 2008, 20(4):501-502.
78. Ozcan O., Selimoglu M.A. Self-injury behavior in an adolescent with Wilson's disease. Eur Child Adolesc Psychiatry Dec 2009, 18(12):761-762.
79. Sahoo M.K., Avasthi A., Sahoo M., Modi M., Biswas P. Psychiatric manifestations of Wilson's disease and treatment with electroconvulsive therapy. Indian J Psychiatry 2010, 52(1):66-68.
80. Sorbello O., Riccio D., Sini M., Carta M., Demelia L. Resolved psychosis after liver transplantation in a patient with Wilson's disease. Clin Pract Epidemiol Ment Health. 2011, 7:182-184.
81. Woerwag-Mehta S., Hindley P., Hedderly T., Dhawan A. Complex psychiatric presentation in adolescent onset Wilson's disease. BMJ Case Rep 2011, 2011:http://dx.doi.org/10.1136/bcr.01.2010.2628.
82. Rybakowski J.K., Litwin T., Chlopocka-Wozniak M., Czlonkowska A. Lithium treatment of a bipolar patient with Wilson's disease: a case report. Pharmacopsychiatry 2013, 46(3):120-121.
83. Sahu J.K., Singhi P., Malhotra S. Late occurrence of isolated obsessive-compulsive behavior in a boy with Wilson's disease on treatment. J Child Neurol 2013, 28(2):277.
84. Dening T.R., Berrios G.E. Wilson's disease: a prospective study of psychopathology in 31 cases. British Journal of Psychiatry. 1989, 155:206-213.
85. Medici V., Mirante V.G., Fassati L.R., et al. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transplantation 2005, 11(9):1056-1063.
86. Svetel M., Pekmezovic T., Tomic A., et al. Quality of life in patients with treated and clinically stable Wilson's disease. Mov Disord 2011, 26(8):1503-1508. doi: http://dx.doi.org/10.1002/mds.23608; http://dx.doi.org/10.1002/mds.23608.
87. Aggarwal A., Aggarwal N., Nagral A., Jankharia G., Bhatt M. A novel global assessment scale for Wilson's disease (GAS for WD). Mov Disord 2009, 24(4):509-518. doi: http://dx.doi.org/10.1002/mds.22231; http://dx.doi.org/10.1002/mds.22231.
88. Eggers B., Hermann W., Barthel H., Sabri O., Wagner A., Hesse S. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease. J Neurol 2003, 250(5):576-580.
89. Hesse S., Barthel H., Schwarz J., Sabri O., Muller U. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev Oct 2004, 28(6):547-563.
90. Dierks T., Kuhn W., Oberle S., Muller T., Maurer K. Generators of brain electrical activity in patients with Wilson's disease. Eur Arch Psychiatry Clin Neurosci 1999, 249(1):15-20.
91. Chu N.S., Chu C.C., Tu S.C., Huang C.C. EEG spectral analysis and topographic mapping in Wilson's disease. J Neurol Sci 1991, 106(1):1-9.
92. Arendt G., Hefter H., Stremmel W., Strohmeyer G. The diagnostic value of multi-modality evoked potentials in Wilson's disease. Electromyogr Clin Neurophysiol 1994, 34(3):137-148.
93. da Costa Mdo D., Spitz M., Bacheschi L.A., Leite C.C., Lucato L.T., Barbosa E.R. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology 2009, 51(10):627-633. 10.1007/s00234-009-0536-5.
94. Piga M., Murru A., Satta L., et al. Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease. Eur J Nucl Med Mol Imaging 2008, 35(4):716-724. doi: http://dx.doi.org/10.1007/s00259-007-0681-1; http://dx.doi.org/10.1007/s00259-007-0681-1.
95. Liebeskind D.S., Wong S., Hamilton R.H. Faces of the giant panda and her cub: MRI correlates of Wilson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2003, 74(5):682.
96. Portala K., Waldenstrom E., von Knorring L., Westermark K. Psychopathology and personality traits in patients with treated Wilson disease grouped according to gene mutations. Ups J Med Sci 2008, 113(1):79-94.
97. Bachmann H., Lossner J., Kuhn H.J., et al. Long-term care and management of Wilson's disease in the GDR. Eur Neurol 1989, 29(6):301-305.
98. Kulaksizoglu I.B., Polat A. Quetiapine for mania with Wilson's disease. Psychosomatics: Journal of Consultation Liaison Psychiatry. 2003, 44(5):438-439.
99. Kontaxakis V., Stefanis C., Markidis M., Tserpe V. Neuroleptic malignant syndrome in a patient with Wilson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1988, 51(7):1001-1002.
100. Volpe F.M., Tavares A. Cyproterone for hypersexuality in a psychotic patient with Wilson's disease. Aust N Z J Psychiatry 2000, 34(5):878-879.
101. Negro Junior P.J., Louza Neto M.R. Results of ECT for a case of depression in Wilson's disease. J Neuropsychiatry Clin Neurosci 1995, 7(3):384.
102. Rodrigues A.C., Dalgalarrondo P., Banzato C.E. Successful ECT in a patient with a psychiatric presentation of Wilson's disease. J ECT 2004, 20(1):55.
103. Krim E., Barroso B. Psychiatric disorders treated with clozapine in a patient with Wilson's disease. Presse Medicale 2001, 30(15):738.
104. Pabon V., Dumortier J., Gincul R., et al. Long-term results of liver transplantation for Wilson's disease. Gastroenterol Clin Biol 2008, 32(4):378-381. doi: http://dx.doi.org/10.1016/j.gcb.2008.01.033; http://dx.doi.org/10.1016/j.gcb.2008.01.033.
105. Geissler I., Heinemann K., Rohm S., Hauss J., Lamesch P. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003, 35(4):1445-1446.
106. Schilsky M.L., Scheinberg I.H., Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology 1994, 19(3):583-587.
107. Freudenreich O., Holt D.J., Cather C., Goff D.C. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry Sep 2007, 15(5):189-211.
108. Cox D.W. A screening test for Wilson's disease and its application to psychiatric patients. Can Med Assoc J 1967, 96(2):83-86.
109. Gedack M., Hanle M.M., SchonfeldtLecuona C., et al. Ceruloplasmin serum concentrations in a large randomized population sample. Nervenheilkunde: Zeitschrift fur interdisziplinaere Fortbildung 2011, 30(8):555-561.
110. Johnson W.T. Copper and brain function 2005, 289-305. Taylor & Francis, US.
111. Madsen E., Gitlin J.D. Copper and iron disorders of the brain. Annu Rev Neurosci. 2007, 30:317-337. 10.1146/annurev.neuro.30.051606.094232.
112. Beard A.W. A review of the literature and case report. Acta Psychiatr Scand 1959, 34(4):411-428. The Association of Hepatolenticular Degeneration with Schizophrenia.
113. Yanik M., Kocyigit A., Tutkun H., Vural H., Herken H. Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 2004, 98(2):109-117.
114. Rahman A., Azad M.A., Hossain I., et al. Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res 2009, 127(2):102-108.
115. Tokdemir M., Polat S.A., Acik Y., Gursu F., Cikim G., Deniz O. Blood zinc and copper concentrations in criminal and noncriminal schizophrenic men. Arch Androl 2003, 49(5):365-368.
116. Lesniak M., Czlonkowska A., Seniow J. Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson's disease. Mov Disord 2008, 23(14):2067-2073. doi: http://dx.doi.org/10.1002/mds.22276; http://dx.doi.org/10.1002/mds.22276.
117. Herran A., Garcia-Unzueta M.T., Fernandez-Gonzalez M.D., Vazquez-Barquero J.L., Alvarez C., Amado J.A. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res 2000, 94(1):51-58.
118. Suzuki T., Koizumi J., Moroji T., et al. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 1992, 31(6):571-581.
119. Bowman M.B., Lewis M.S. The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 1982, 6(3):321-328.
120. Wolf T.L., Kotun J., Meador-Woodruff J.H. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr Res 2006, 86(1-3):167-171.
121. Jeon B., Kim J.M., Jeong J.M., et al. Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998, 65(1):60-64.
122. Herring N.R., Konradi C. Myelin, copper, and the cuprizone model of schizophrenia. Frontiers in Bioscience. 2011, 3:23-40.
123. Sathyanarayana Rao T.S., Zecca L., Rao K.J. Tracemetals, neuromelanin and neurodegeneration: an interesting area for research. Indian J Psychiatry 2007, 49(3):154-156. doi: http://dx.doi.org/10.4103/0019-5545.37310; http://dx.doi.org/10.4103/0019-5545.37310.
124. Virit O., Selek S., Bulut M., et al. High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study. Behavioral and Brain Functions 2008, 4:52.
125. Nahar Z., Azad M.A., Rahman M.A., et al. Comparative analysis of serum manganese, zinc, calcium, copper and magnesium level in panic disorder patients. Biol Trace Elem Res 2010, 133(3):284-290.